Austin Pharmacy to Pay $200,000 in Civil Penalties for Alleged Violations of the Controlled Substances Act
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Sobrescribir enlaces de ayuda a la navegación

  • Inicio
  • Austin Pharmacy to Pay $200,000 in Civil Penalties for Alleged Violations of the Controlled Substances Act

Austin Pharmacy to Pay $200,000 in Civil Penalties for Alleged Violations of the Controlled Substances Act

Agosto 17, 2023
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Sally M. Sparks
Phone Number:

AUSTIN, Texas – People’s Pharmacy Inc. has agreed to pay $200,000 in civil penalties to resolve allegations that it violated provisions of the Controlled Substances Act (CSA).

People’s Pharmacy Inc., doing business as Peoples Rx, operates five retail pharmacies and one compounding laboratory in the Austin area. During a routine inspection of a Peoples Rx location in June 2022, DEA diversion investigators determined that the pharmacy had violated certain regulatory recordkeeping provisions, improperly dispensed controlled substances to practitioners for office use, and issued prescriptions without authorization.
During their inspection, DEA diversion investigators also learned that Peoples Rx had sold pseudoephedrine products without self-certifying as required by the Combat Methamphetamine Epidemic Act of 2005 (CMEA).

The CMEA regulates over-the-counter sales of ephedrine, pseudoephedrine, and phenylpropanolamine products, which are common ingredients in cough, cold, and allergy products that serve as precursor chemicals used in the illicit manufacture of methamphetamine or amphetamine.

Retail provisions of the CMEA include daily sales limits and 30-day purchase limits, placement of product out of direct customer access, sales logbooks, customer ID verification, employee training, and self-certification of regulated sellers.


The Diversion Control Unit in DEA’s San Antonio District Office led the investigation of this matter. The primary goal of the DEA’s diversion control program is to prevent, detect, and investigate the diversion of controlled substances from their lawful purpose into illicit drug traffic. In furtherance of this goal, DEA conducts inspections of pharmacies and other DEA registrants to ensure compliance with regulatory requirements relating to drug security and recordkeeping.


Assistant U.S. Attorney Thomas Parnham negotiated the settlement on behalf of the government.


The claims resolved by the settlement are allegations only and there has been no determination of liability.
 

Download Press Release
###
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Jonathan Pullen Special Agent in Charge - Houston
@DEAHoustonDiv
  • Facebook
  • X
  • Email
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster